PlainVisa
2026 data Public-data reference Official source

Novo Nordisk, Inc.

A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.

DOL LCA filings
84
DOL-certified
98.8%
Median offered wage
$158,665

Plainsboro, NJ NAICS: 4242

How many H-1B LCA filings list Novo Nordisk, Inc.?

U.S. Department of Labor's OFLC discloses 84 Labor Condition Application filings naming Novo Nordisk, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs

How many H-1B petitions has USCIS approved for Novo Nordisk, Inc.?

Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 113 H-1B petitions naming Novo Nordisk, Inc. through FY2024, and approved nearly every one of them: 99.1% approved (112 approvals, 1 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.

The verdict

Novo Nordisk, Inc. is listed in 84 DOL LCA filings, more filings than 97% of employer filers in this extract. DOL certified 98.8% of those LCAs; the median listed offered wage is $158,665. This is not a USCIS approval, hiring, or sponsorship ranking.

84
DOL LCA filings, FY2023–FY2026
98.8%
DOL-certified
$158,665
median offered wage
Top 3%
of employer filers by volume

According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Plainsboro, NJ.

Saved on this device only, no account, no email. Open saved list Follow this profile's data updates Updates when the published DOL data vintage changes; this is a feed, not an alert service.

Novo Nordisk, Inc. vs all U.S. employer filers by LCA volume

Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)

84 3118th of 122824 higher than 119,706 of 122,824 employer filers

Employer filers, banded by disclosed H-1B LCA filing count

Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source U.S. Department of Labor OFLC · FY2023–FY2026

LCA filing shape · Novo Nordisk, Inc.

Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.

Offered-wage span on file: $65,000$330,000 .

Title concentration

  • Senior Architect - Solutions 4 · 4.8% · $164,000
  • ASSOC DIR - FORECASTING & INNOVATION 3 · 3.6% · $201,157
  • Senior Manager - Real World Evidence- Data Science 2 · 2.4% · $156,500
  • Senior Manager - New Product Commercialization 2 · 2.4% · $175,000
  • SR MGR - FORECASTING 2 · 2.4% · $179,400

Worksite counties

  • MIDDLESEX, NJ 61 · 84.7%
  • LEXINGTON, MA 4 · 5.6%
  • WATERTOWN CITY, MA 4 · 5.6%
  • SOMERSET, NJ 2 · 2.8%
  • MERCER, NJ 1 · 1.4%

DOL LCA release change

What changed between the two LCA fiscal years

FY2024 -> FY2025
  • Novo Nordisk, Inc.'s disclosed H-1B LCA filing count rose from 22 in FY2024 to 26 in FY2025 (+18.2%).

Arithmetic differences between stored DOL OFLC Labor Condition Application disclosure fiscal years for this employer identity - not a headcount, hire forecast, or cause claim. Role mix can shift between years even when the filing total is flat. Totals group name variants that share the same identity key.

National filing changes Two-year CSV

Above-prevailing wage posture

On 83 LCAs with comparable offered vs prevailing wages, Novo Nordisk, Inc. averages about 20.4% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (53.6% of LCA filings).

Middlesex, NJ worksite concentration

Only 84 LCAs on file for Novo Nordisk, Inc., and 72.6% land in MIDDLESEX, NJ. Treat rates as descriptive of a small sample. DOL cert on file: 98.8%.

Certification Rate

98.8%

Very high DOL cert

Avg. Salary

$158,665

Well above portal avg

Total Workers

84

Moderate worker count

Wondering how long it takes USCIS to process an H-1B petition for this employer? See current I-129 processing times →

Salary Analysis

Compensation range for H-1B positions at Novo Nordisk, Inc.

Minimum
$65,000
Maximum
$330,000
Average Salary
$158,665

Wage vs. DOL Minimum

+20.4%

Above DOL floor

national avg +17.8%

Typical DOL Wage Level

Fully Competent (Level IV)

53.6% of LCA filings

Full-Time Positions

100%

Primary Worksite County

MIDDLESEX, NJ

72.6% of LCA filings

Top Occupations

Most frequently listed job titles at Novo Nordisk, Inc.

Job Title LCA filings Avg. Salary
Senior Architect - Solutions 4 $164,000
ASSOC DIR - FORECASTING & INNOVATION 3 $201,157
Senior Manager - Real World Evidence- Data Science 2 $156,500
Senior Manager - New Product Commercialization 2 $175,000
SR MGR - FORECASTING 2 $179,400
SR ASSOC - SAMPLE OPERATIONS SUPPORT 2 $105,060
SR ANALYST - MASTER DATA MANAGEMENT 2 $106,080
Manager- Forecasting & Planning 2 $155,000
Manager - Forecasting & Planning 2 $161,720
MGR - NNI CONSULTING 2 $187,200
MGR - FORECASTING & PLANNING 2 $168,730
MGR - EVIDENCE GENERATION 2 $156,600
Lead Statistical Programmer 2 $165,000
IT Agile Product Manager 2 $172,200
DATA SCIENTIST II - ADVANCED ANALYTICS 2 $138,276

Nationwide peers near Novo Nordisk, Inc.'s 84-LCA band

Cross-state DOL neighbors for Novo Nordisk, Inc. - LCA filing-count and offered-wage axes, outside NJ.

Similar LCA filing volume

Nearest cross-state employer filers by LCA filing count (84 here; floor ≥10 LCA filings).

Similar avg offered wage

Cross-state employer filers with a comparable average listed offered wage ($158,665 here).

Frequently Asked Questions

How many H-1B LCA filings list Novo Nordisk, Inc.?

Novo Nordisk, Inc. is listed in 84 DOL Labor Condition Application filings covering 84 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.

How does Novo Nordisk, Inc.'s LCA filing volume compare to other employer filers?

Among 122,824 employer filers in the DOL disclosure extract, Novo Nordisk, Inc. ranks #3081 by total LCA filing count (84 filings). 119,706 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.

What is the H-1B DOL certification rate for Novo Nordisk, Inc.?

Novo Nordisk, Inc. has a 98.8% DOL certification rate, with 83 out of 84 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.

What offered wage is listed in LCAs for Novo Nordisk, Inc.?

The average offered wage listed in Novo Nordisk, Inc.'s LCAs is $158,665. Listed wages range from $65,000 to $330,000 and are not verified actual compensation.

What are the most common H-1B job titles at Novo Nordisk, Inc.?

The top job titles in Novo Nordisk, Inc.'s LCA filing records include Senior Architect - Solutions, ASSOC DIR - FORECASTING & INNOVATION, Senior Manager - Real World Evidence- Data Science. The most common listed title is Senior Architect - Solutions with 4 LCA filings at an average listed offered wage of $164,000. This does not establish actual job openings, hiring, or approved petitions.

Where is Novo Nordisk, Inc. located?

Novo Nordisk, Inc. is headquartered in Plainsboro, NJ. Their H-1B workers are distributed across 2 states, with the most positions in NJ, MA.

Is Novo Nordisk, Inc. H-1B dependent?

No, Novo Nordisk, Inc. is not classified as H-1B dependent.

How have Novo Nordisk, Inc.'s listed LCA filings changed over time?

Novo Nordisk, Inc. is listed in 18 LCA filings in FY2023 and 18 in FY2026. The average listed offered wage increased from $154,415 to $157,460. This historical filing series does not predict sponsorship, hiring, or visa outcomes.

Data sourced from U.S. Department of Labor LCA disclosure filings. See our methodology for details.

Disclaimer: Informational only, not professional advice.

Read with Novo Nordisk, Inc.

ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-CLEAN · WAGE-ELITE.

What to do with this profile

Use the DOL LCA record for Novo Nordisk, Inc. to compare filing volume and offered wages, not USCIS outcomes.

DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.

Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.